Latest News & Features
Americas
Late last week, the Patent Trial and Appeal Board rejected a Native American tribe’s attempt to dismiss inter partes reviews based on the tribe’s sovereign immunity claims. 1 March 2018
Americas
The US Food and Drug Administration has introduced a pilot scheme for processing orphan designation requests more efficiently, as part of its commitment to support and expedite the development of rare disease products. 28 February 2018
Big Pharma
The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March. 27 February 2018
Americas
Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer. 26 February 2018
Americas
The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week. 26 February 2018
Americas
Japan-based Takeda Pharmaceuticals has entered into a global strategic collaboration with Wave Life Sciences. 23 February 2018
Biotechnology
The EU General Court has crushed a company’s attempt to protect the Gala Schnico apple variety, today affirming a decision of the Community Plant Variety Office. 23 February 2018
Big Pharma
Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy. 22 February 2018
Asia
More than £500 million worth of life sciences and healthcare agreements were signed between the UK and China during the UK Prime Minister’s visit to China earlier this month. 21 February 2018
Big Pharma
Infringement and plausibility were the biggest issues on the battleground in the UK Supreme Court’s hearing in a case dealing with second medical use patents, as Claire Phipps-Jones, Katie Cambrook and Rachel Mumby of Bristows report. 21 February 2018